Mark R. Silvis
Impact in
- Cell Biology top 2%
- Hippo pathway signaling and YAP/TAZ
- Cellular transport and secretion
- Cellular Mechanics and Interactions
-
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
Papers in
-
- Melanoma and MAPK Pathways 3
-
- Cystic Fibrosis Research Advances 3
- Neonatal Respiratory Health Research 3
- Advanced Breast Cancer Therapies 2
- Co-authors
- Valeri Vasioukhin (3 shared papers)Neil A. Bradbury (4 shared papers)Wen‐Hui Lien (2 shared papers)Nadia A. Ameen (2 shared papers)Olga Klezovitch (2 shared papers)Fernando D. Camargo (1 shared paper)Bridget Kreger (1 shared paper)John T. Seykora (1 shared paper)
- Journals
- Molecular Biology of the Cell (2 papers)Cancer Research (2 papers)eLife (2 papers)JNCI Journal of the National Cancer Institute (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Mark R. Silvis
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Cell Biology 636
- Molecular Biology 625
- Genetics 79
- Pulmonary and Respiratory Medicine 209
- Cancer Research 81
Countries citing papers authored by Mark R. Silvis
This map shows the geographic impact of Mark R. Silvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Silvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Silvis more than expected).
Fields of papers citing papers by Mark R. Silvis
This network shows the impact of papers produced by Mark R. Silvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Silvis. The network helps show where Mark R. Silvis may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Silvis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 282 | |
| 2 | 2016 | 153 | |
| 3 | 2007 | 109 | |
| 4 | 2009 | 100 | |
| 5 | 2015 | 95 | |
| 6 | 2006 | 82 | |
| 7 | 2018 | 80 | |
| 8 | 2011 | 52 | |
| 9 | 2016 | 49 | |
| 10 | 2019 | 47 | |
| 11 | 2003 | 37 | |
| 12 | 2018 | 26 | |
| 13 | 2023 | 22 | |
| 14 | 2024 | 10 | |
| 15 | 2017 | 9 | |
| 16 | 2024 | 7 | |
| 17 | 2018 | 3 | |
| 18 | 2023 | 0 | |
| 19 | 2019 | 0 |
About Mark R. Silvis
Mark R. Silvis is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology, Oncology and Genetics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (3 papers), Melanoma and MAPK Pathways (3 papers), Cystic Fibrosis Research Advances (3 papers), Neonatal Respiratory Health Research (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Cellular transport and secretion (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cell Biology (636 citations), Molecular Biology (625 citations), Genetics (79 citations), Pulmonary and Respiratory Medicine (209 citations) and Cancer Research (81 citations). Mark R. Silvis has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Valeri Vasioukhin, Neil A. Bradbury, Wen‐Hui Lien, Nadia A. Ameen, Olga Klezovitch, Fernando D. Camargo, Bridget Kreger, John T. Seykora, Yuchi Honaker and Sarah T. Arron. Their work appears in journals such as Molecular Biology of the Cell, Cancer Research, eLife, JNCI Journal of the National Cancer Institute and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.